We look forward to follow-up studies on the Alzheimer's disease patients in the current trial to see if continued treatment with deprenyl or vitamin E continues to provide benefits for the patients as their disease progresses. The Foundation continues to recommend deprenyl as an anti-aging therapy in healthy persons over 40, given at a dose of 10 to 15 mg a week. That is much lower than the doses of the drug tested in Parkinson's disease and Alzheimer's disease patients. At these doses, there is no evidence of adverse side effects and ample evidence suggesting that deprenyl may slow brain aging. In the case of vitamin E, this is the latest in a series of findings indicating that supplementing vitamin E is one of the best aids to health and longevity.
Evidence shows that vitamin E protects against neuron damage and heart attacks.
Evidence also shows that vitamin E improves the immune system to help protect us against infectious diseases. New evidence suggests that a daily dose of 400 IU of vitamin E is appropriate for general health protection.